Streetbeat News

Price Targets

COUR

Cantor Fitzgerald analyst Brett Knoblauch has upgraded Coursera (NYSE:COUR) from Neutral to Overweight and raised the price target from $13 to $17.

Portfolio Pulse from richadhand@benzinga.com

July 28, 2023 | 9:15 am

CROX

Stifel analyst Jim Duffy has upgraded Crocs (NASDAQ:CROX) from Hold to Buy and announced a price target of $130.

Portfolio Pulse from richadhand@benzinga.com

July 28, 2023 | 9:14 am

XPEV

Jefferies analyst Johnson Wan has upgraded XPeng (NYSE:XPEV) from Hold to Buy and raised the price target from $7.8 to $25.3.

Portfolio Pulse from richadhand@benzinga.com

July 28, 2023 | 9:13 am

F

RIVN

TSLA

Needham analyst Chris Pierce has increased the price target for Rivian Automotive, Inc. (NASDAQ:RIVN) from $28 to $31, suggesting a 19% upside from the current levels. This comes ahead of Rivian’s Q2 results and follows another iteration of its electric vehicle OEM used vehicle price tracker. Pierce also compared Rivian to Ford Motor Co.’s (NYSE:F) F-150 Lightning, noting that Rivian performed better in Needham’s weekly check of used vehicle prices. Rivian's stock ended Thursday's session down 4.05% at $26.05.

Portfolio Pulse from Shanthi Rexaline

July 28, 2023 | 9:11 am

TW

Raymond James analyst Patrick O'Shaughnessy has maintained an 'Outperform' rating on Tradeweb Markets (NASDAQ:TW) and raised the price target from $84 to $87.

Portfolio Pulse from richadhand@benzinga.com

July 28, 2023 | 9:09 am

TMO

Raymond James analyst Andrew Cooper maintains an Outperform rating on Thermo Fisher Scientific (NYSE:TMO) and raises the price target from $595 to $630.

Portfolio Pulse from richadhand@benzinga.com

July 28, 2023 | 9:08 am

FTAI

Raymond James analyst Robert Dodd maintains an Outperform rating on FTAI Aviation and raises the price target from $31 to $37.5.

Portfolio Pulse from richadhand@benzinga.com

July 28, 2023 | 9:07 am

CBRE

Raymond James analyst Patrick O'Shaughnessy has maintained a Strong Buy rating on CBRE Group but lowered the price target from $102 to $100.

Portfolio Pulse from richadhand@benzinga.com

July 28, 2023 | 9:06 am

WTW

Raymond James analyst C. Gregory Peters has downgraded Willis Towers Watson (NASDAQ:WTW) from Strong Buy to Outperform and lowered the price target from $270 to $260.

Portfolio Pulse from richadhand@benzinga.com

July 28, 2023 | 9:05 am

WST

Keybanc analyst Paul Knight maintains an Overweight rating on West Pharmaceutical Servs (NYSE:WST) and raises the price target from $375 to $385.

Portfolio Pulse from richadhand@benzinga.com

July 28, 2023 | 9:03 am